Unknown

Dataset Information

Real-world analysis of medication adherence and cost of care for comorbid conditions in patients with early Alzheimer's disease in the U.S.


ABSTRACT:

Aim

To understand medication adherence and associated healthcare costs of patients with early Alzheimer's disease (AD).

Methods

This retrospective cohort study used the Axon Registry® linked with claims data to examine medication adherence of U.S. patients with early AD (mild cognitive impairment [MCI] and mild dementia due to AD) from 2015 to 2022. Medication adherence was quantified by the proportion of days covered (PDC) over a one-year follow-up, and adherence rate was defined at a PDC ≥ 80%. Patient comorbidities and healthcare costs were described.

Results

Of 333 patients included, 213 (64%) were female with a median (IQR) age 79 (72-83) years. Patients had a mean (SD) of 2.3 (2.1) comorbidities and took a mean (SD) of 3.0 (1.5) medications. Weighted-average PDC

SUBMITTER: Lv L 

PROVIDER: S-EPMC12826706 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature